CPIX Stock Analysis: Buy, Sell, or Hold?
CPIX - Cumberland Pharmaceuticals Inc
$4.06
0.16 (4.10%)
▲
5d:
+25.7%
30d:
+21.19%
90d:
+3.31%
WAIT
LOW Confidence
Analysis Updated: Apr 24, 2026 12:00 AM ET
Earnings: May 05, 2026
9d
Smart Money Distribution
CPIX is up 26.6% this week, but smart money is buying puts. Top strike: $5 2026-07-17 with 310 OI. Put ratio: 63% View Scanner →
Strength: 10.0/10
Get Alerted When CPIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CPIX is 19.1% above fair value ($3.41). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CPIX is 19.1% above fair value ($3.41). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CPIX is currently trading at $4.06, which is considered extended relative to its 30-day fair value range of $2.91 to $3.41.
Technical Outlook: Technically, CPIX is showing sideways momentum. Immediate support is located at $2.98, while resistance sits at $6.04. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: CPIX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+109.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CPIX is showing sideways momentum. Immediate support is located at $2.98, while resistance sits at $6.04. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: CPIX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.50 (+109.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$2.91 -
$3.41
Company Quality Score
55/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+19.1% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+4.1%)
- BULLISH: Trading 109.4% below Wall St target ($8.50)
- WARNING: Recommendation downgraded due to 19.1% overvaluation
Fair Price Analysis
30-Day Fair Range
$2.91 -
$3.41
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$2.98
Resistance Level
$6.04
Current Trend
Sideways
Technical data as of
Apr 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
50.00
Wall Street Target
$8.50
(+109.4%)
Revenue Growth (YoY)
31.1%
Profit Margin
-6.4%
Share & Embed Analysis
Last updated: April 25, 2026 7:15 AM ET
Data refreshes hourly during market hours. Next update: 8:15 AM
Data refreshes hourly during market hours. Next update: 8:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CPIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$185 | 59 HOLD |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$151 | 53 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$91 | 61 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
